Clinical Overview
Lamotrigine is an anticonvulsant with mood-stabilizing properties indicated for epilepsy and bipolar disorder maintenance. It is particularly valuable for preventing depressive episodes in bipolar disorder and has a relatively favorable side effect profile compared to other mood stabilizers.
Primary Clinical Applications
Lamotrigine is indicated for partial seizures, primary generalized tonic-clonic seizures, and Lennox-Gastaut syndrome in epilepsy patients. In psychiatry, it is used for maintenance treatment of bipolar I disorder to delay mood episodes, with particular efficacy in preventing depression.
Mechanism and Clinical Benefits
Lamotrigine stabilizes neuronal membranes by blocking voltage-sensitive sodium channels and inhibiting glutamate release. This mechanism provides both anticonvulsant and mood-stabilizing effects. Unlike lithium or valproate, lamotrigine does not typically cause weight gain or metabolic effects.
Dosing Considerations and Safety
Lamotrigine requires very slow dose titration to minimize the risk of serious rash, including Stevens-Johnson syndrome. The titration schedule is significantly affected by concurrent medications, particularly enzyme inducers and inhibitors, requiring careful attention to drug interactions.
Prescribing Information
Dosing & Administration
Bipolar Disorder Maintenance (not taking enzyme inducers/inhibitors):
- Weeks 1-2: 25 mg once daily
- Weeks 3-4: 50 mg once daily
- Week 5: 100 mg once daily
- Week 6: 200 mg once daily (target maintenance dose)
With Valproate (enzyme inhibitor):
- Weeks 1-2: 25 mg every other day
- Weeks 3-4: 25 mg once daily
- Week 5: 50 mg once daily
- Week 6: 100 mg once daily (target maintenance dose)
With Enzyme Inducers (carbamazepine, phenytoin):
- Weeks 1-2: 50 mg once daily
- Weeks 3-4: 100 mg daily in divided doses
- Week 5: 200 mg daily in divided doses
- Week 6: 300-400 mg daily in divided doses
Indications
- Partial seizures (adjunctive therapy, ages 2+)
- Primary generalized tonic-clonic seizures (adjunctive, ages 2+)
- Lennox-Gastaut syndrome (adjunctive, ages 2+)
- Bipolar I disorder maintenance treatment (ages 18+)
Contraindications
- Hypersensitivity to lamotrigine or any component
- History of lamotrigine-related rash
Warnings & Precautions
- Boxed Warning: Serious rash including Stevens-Johnson syndrome and toxic epidermal necrolysis
- Aseptic meningitis: Discontinue if suspected
- Blood dyscrasias: Monitor for signs of bone marrow suppression
- Suicidal thoughts and behavior: Monitor for mood changes
- Withdrawal seizures: Taper gradually over ≥2 weeks
- Cardiac rhythm and conduction abnormalities
Drug Interactions
- Valproate: Increases lamotrigine levels – reduce lamotrigine dose by 50%
- Enzyme inducers: Decrease lamotrigine levels – increase lamotrigine dose
- Oral contraceptives: Decrease lamotrigine levels during active pills
- Rifampin: Significantly decreases lamotrigine levels
Adverse Reactions
Common (≥10%):
- Dizziness, headache, diplopia, ataxia, nausea, blurred vision
Serious:
- Serious rash (0.3% in adults, 0.8% in pediatrics)
- Aseptic meningitis, blood dyscrasias
Special Populations
- Renal Impairment: Reduce maintenance dose by 25-50% for significant impairment
- Hepatic Impairment: Reduce dose by 25% (moderate) to 50% (severe)
- Pregnancy: Category C – benefits may outweigh risks
- Pediatric: Higher risk of serious rash (0.8% vs 0.3% in adults)
Medical Disclaimer: This information is for educational purposes only and is not intended as medical advice. Always consult with qualified healthcare professionals before making any treatment decisions. Individual patient circumstances may vary significantly.
